These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 35135134)
1. Translating Gene Signatures Into a Pathologic Feature: Tumor Necrosis Predicts Disease Relapse in Operable and Stage I Lung Adenocarcinoma. Lin EP; Hsiao TH; Lu JY; Wong SH; Lu TP; Peck K; Takahashi T; Yang PC JCO Precis Oncol; 2018 Nov; 2():1-13. PubMed ID: 35135134 [TBL] [Abstract][Full Text] [Related]
2. Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance. Chang WH; Forde D; Lai AG Cancer Commun (Lond); 2019 Apr; 39(1):23. PubMed ID: 31036064 [TBL] [Abstract][Full Text] [Related]
4. Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival. Sun Z; Wigle DA; Yang P J Clin Oncol; 2008 Feb; 26(6):877-83. PubMed ID: 18281660 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological, gene expression and genetic features of stage I lung adenocarcinoma with necrosis. Oiwa H; Aokage K; Suzuki A; Sato K; Kuroe T; Mimaki S; Tane K; Miyoshi T; Samejima J; Tsuchihara K; Goto K; Funai K; Tsuboi M; Nakai T; Ishii G Lung Cancer; 2021 Sep; 159():74-83. PubMed ID: 34311347 [TBL] [Abstract][Full Text] [Related]
6. Hybrid models identified a 12-gene signature for lung cancer prognosis and chemoresponse prediction. Wan YW; Sabbagh E; Raese R; Qian Y; Luo D; Denvir J; Vallyathan V; Castranova V; Guo NL PLoS One; 2010 Aug; 5(8):e12222. PubMed ID: 20808922 [TBL] [Abstract][Full Text] [Related]
7. A seven-long noncoding RNA signature predicts relapse in patients with early-stage lung adenocarcinoma. Zhou H; Zhang H; Chen J; Cao J; Liu L; Guo C; Huang G; Zeng D J Cell Biochem; 2019 Sep; 120(9):15730-15739. PubMed ID: 31050375 [TBL] [Abstract][Full Text] [Related]
8. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics. Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158 [TBL] [Abstract][Full Text] [Related]
9. Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma. Wan YW; Beer DG; Guo NL Lung Cancer; 2012 Apr; 76(1):98-105. PubMed ID: 22047960 [TBL] [Abstract][Full Text] [Related]
10. Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas. Menor M; Zhu Y; Wang Y; Zhang J; Jiang B; Deng Y BMC Med Genomics; 2019 Jan; 12(Suppl 1):24. PubMed ID: 30704450 [TBL] [Abstract][Full Text] [Related]
11. High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma. Anagnostou VK; Bepler G; Syrigos KN; Tanoue L; Gettinger S; Homer RJ; Boffa D; Detterbeck F; Rimm DL Clin Cancer Res; 2009 Jun; 15(12):4157-64. PubMed ID: 19509151 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Immune Implication and Prognostic Value of Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W Front Oncol; 2021; 11():798425. PubMed ID: 35047409 [TBL] [Abstract][Full Text] [Related]
13. A robust prognostic gene expression signature for early stage lung adenocarcinoma. Krzystanek M; Moldvay J; Szüts D; Szallasi Z; Eklund AC Biomark Res; 2016; 4():4. PubMed ID: 26900477 [TBL] [Abstract][Full Text] [Related]
14. Robust prognostic gene expression signatures in bladder cancer and lung adenocarcinoma depend on cell cycle related genes. Dancik GM; Theodorescu D PLoS One; 2014; 9(1):e85249. PubMed ID: 24465512 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma. Wu P; Zheng Y; Wang Y; Wang Y; Liang N J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329 [TBL] [Abstract][Full Text] [Related]
17. Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma. Ringnér M; Staaf J Oncotarget; 2016 Aug; 7(33):52957-52973. PubMed ID: 27437773 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma. Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382 [TBL] [Abstract][Full Text] [Related]
19. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Raponi M; Zhang Y; Yu J; Chen G; Lee G; Taylor JM; Macdonald J; Thomas D; Moskaluk C; Wang Y; Beer DG Cancer Res; 2006 Aug; 66(15):7466-72. PubMed ID: 16885343 [TBL] [Abstract][Full Text] [Related]
20. A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis. Kadara H; Behrens C; Yuan P; Solis L; Liu D; Gu X; Minna JD; Lee JJ; Kim E; Hong WK; Wistuba II; Lotan R Clin Cancer Res; 2011 Mar; 17(6):1490-501. PubMed ID: 21163870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]